The hepatic nuclear factor-1α G319S variant is associated with early- onset type 2 diabetes in Canadian Oji-Cree

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 3, 1999, Pages 1077-1082

  Hegele, Robert A ^a   Cao, Henian ^a   Harris, Stewart B ^b   Hanley, Anthony J G ^c   Zinman, Bernard ^c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCINE; INSULIN; NUCLEAR FACTOR I;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY MASS; CANADA; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HOMOZYGOTE; HUMAN; INSULIN BLOOD LEVEL; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033027001     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.3.5528     Document Type: Article

References (32)

1. Harris SB, Gittelsohn J, Hanley AJG, et al. 1997 The prevalence of NIDDM, and associated risk factors in native Canadians. Diabetes Care. 20:185-197
2. Gittelsohn J, Wolever TM, Harris SB, Harris-Giraldo R, Hanley AJ, Zinman B. 1998 Specific patterns of food consumption and preparation are associated with diabetes and obesity in a native Canadian community. J Nutr. 128541-547
3. Gittelsohn J, Harris SB, Burris KL, et al. 1996 Use of ethnographic methods for applied research on diabetes among the Ojibway-Cree in northern Ontario. Health Educ Q. 23:365-382
4. Hanley AJ, Harris SB, Gao XJ, Kwan J, Zinman B. 1997 Serum immunoreactive leptin concentrations in a Canadian aboriginal population with high rates of NIDDM. Diabetes Care. 0:1408-1415
5. Hegele RA, Harris SB, Hanley AJ, Sadikian S, Connelly PW, Zinman B. 1996 Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab. 81:4334-4337
6. Hegele RA, Connelly PW, Scherer SW, et al. 1997 Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulindependent diabetes mellitus. J Clin Endocrinol Metab. 82:3373-3377.
7. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC, Zinman B. 1997 Paraoxonase-2 G148 variant in an aboriginal Canadian girl with non-insulin-dependent diabetes. Lancet. 350:785
8. Hegele RA, Harris SB, Hanley AJ, Azouz H, Connelly PW, Zinman B. 1998 Absence of association between genetic variation of the β3-adrenergic receptor and metabolic phenotypes in Oji-Cree. Diabetes Care. 21:851-854
9. Hegele RA, Wolever TM, Hanley AJ, Harris SB, Zinman B. 1998 Methylenetetrahydrofolate reductase gene, dietary folate, NIDDM, and atherosclerosis in Canadian Oji-Cree. Diabetes Care. 21:322-323
10. Hegele RA, Harris SB, Zinman B. 1998 Hemochromatosis and diabetes mellitus. Ann Intern Med. 129:587
11. Courtois G. Morgan JG, Campbell LA, Fourel G, Crabtree GR. 1987 Interaction of a liver-specific nuclear factor with the fibrinogen and α-1-antitrypsin promoters. Science. 238:688-692
12. Cereghini S. 1996 Liver-enriched transcription factors, and hepatocyte differentiation. FASEB J. 238:267-282
13. Bach I, Galcheva-Gargova Z, Mattei MG. Simon-Chazottes D, Guenet J-L, Cereghini S, Yaniv M. 1990. Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse. Genomics. 8:155-164
14. Yamagata K, Oda N, Kaisaki PJ, et al. 1996 Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young Nature. 384:455-458.
15. Gragnoli C, Lindner T, Cockburn BN, Kaisaki PJ, Gragnoli F, Marozzi G, Bell GI. 1997 Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4α binding site in the promoter of the hepatocyte nuclear factor-1α gene. Diabetes. 46:1648-1651
16. Kaisaki PJ, Menzel S, Lindner T, et al. 1997 Mutations in the hepatocyte nuclear factor-1α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes. 46:528-535
17. Iwasaki N, Oda N, Ogata M, et al. 1997 Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes. 46:1504-1508
18. Frayling TM, Bulamn MP, Ellard S, et al. 1997 Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the U.K. Diabetes. 46:720-725
19. Awata T, Kurihara S, Inoue K, et al. 1998 A novel missense mutation in the homeodomain of the hepatic nuclear factor-1α/maturity-onset diabetes of the young 3 in a Japanese early-onset type 2 diabetic patient and time-course of glucose-stimulated insulin secretion. Diabetes Care. 21:1569-1571
20. Yamada S, Nishigori H, Onda H, et al. 1997 Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of late-onset NIDDM in Japanese subjects. Diabetes. 46:1512-1513
21. Nishigori H, Yamada S, Kohama T, Utsugi T, Shimizu H, Takeuchi T, Takeda J. 1998 Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese. J Hum Genet. 43:107-110
22. Frayling TM, Bulman MP, Appleton M, Hattersley AT, Ellard S. 1997 A rapid screening method for hepatocyte nuclear factor 1α frameshift mutations; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Hum Genet. 101:351-354
23. Nagashima K, Nagai R, Morikawa A, Takeuchi T, Takeda J. 1997 Identification of mutations in the hepatocyte nuclear factor (HNF)-1α gene in Japanese subjects with IDDM. Diabetes. 46:1643-1647
24. Lento M, Tuomi T, Mahtani MM, et al. 1997 Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest. 99:582-591
25. Pontoglio M, Sreenan S, Roe M, et al. 1998 Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest. 101:2215-2222
26. Yamagata K, Yang Q, Yamamoto K, et al. 1998 291fsinsC in the transcription factor hepatocyte nuclear factor-1α is dominant negative. Diabetes. 47:1231-1235
27. Surmely JF, Guenat E, Philippe J, et al. 1998 Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor-1α gene. Diabetes. 47:1459-1463
28. Hansen T, Eiberg H, Rouard M, et al. 1997 Novel MODY3 mutations in the hepatocyte nuclear factor-1α gene: evidence for a hyperexcitability of pancreatic β-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes. 46:726-730
29. Vaxillaire M, Rouard M, Yamagata K, et al. 1997 Identification of nine novel mutations in the hepatocyte nuclear factor 1α gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet. 6:583-586
30. Glucksmann MA, Lehto M, Tayber O, et al. 1997 Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes, 46:1081-1086
31. SAS Institute. 1987 SAS/STAT guide for personal computers. Cary: SAS Institute
32. Isomaa B, Henricsson M, Lehto M, et al. 1998 Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia. 41:467-473